Cost-effectiveness analysis of different rescue therapies in patients with lamivudine-resistant chronic hepatitis B in China. [electronic resource]
Producer: 20130701Description: 385 p. digitalISSN:- 1472-6963
- Adult
- Antiviral Agents -- administration & dosage
- China
- Cohort Studies
- Cost-Benefit Analysis
- Drug Resistance, Viral
- Drug Therapy, Combination -- economics
- Emergency Treatment -- economics
- Female
- Hepatitis B e Antigens -- blood
- Hepatitis B virus -- drug effects
- Hepatitis B, Chronic -- drug therapy
- Humans
- Lamivudine -- economics
- Male
- Markov Chains
- Organophosphonates -- administration & dosage
- Patient Simulation
- Predictive Value of Tests
- Quality-Adjusted Life Years
- Sensitivity and Specificity
- Viral Load
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.